Journal of Cardiovascular Pharmacology

OCT 7, 2026 · JOURNAL ARTICLE

Rationale and Design of the CARdio-Tox Study: A Prospective Evaluation of Cardiovascular Toxicity in Patients Receiving Chimeric Antigen Receptor-T (CAR-T) Cell Therapy

Journal of Cardiovascular Pharmacology

Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as an innovative treatment of haematologic malignancies; however, its use is frequently complicated by Cytokine Release S

JUN 26, 2026 · JOURNAL ARTICLE

Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia

Journal of Cardiovascular Pharmacology

Phase III trial demonstrates robust triglyceride reduction and favorable safety in a specific high-risk population, but lacks hard clinical outcome data and generalizability beyond familial chylomicronemia syndrome.